Showing results (1-10 of 44) with videos related to
Sort By:
Pageof 5
Revista Latino-Americana De Enfermagem|January 1, 1996
[The situation of nursing research in Sao Paulo municipal hospitals]N Piva Adami, S Della Torre Salzano, R A Pimenta de Castro, et al.The International Journal of Biological Markers|January 14, 2005
Accuracy and clinical correlates of two different methods for chromogranin A assay in neuroendocrine tumorsL Ferrari, E Seregni, G Lucignani, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 9, 2005
Is the new WHO classification of neuroendocrine tumours useful for selecting an appropriate treatment?E Bajetta, L Catena, G Procopio, et al.The Astrophysical Journal|October 14, 2021
Deciphering the Local Interstellar Spectra of Secondary Nuclei with the Galprop/Helmod Framework and a Hint for Primary Lithium in Cosmic RaysM J Boschini, S Della Torre, M Gervasi, et al.The Astrophysical Journal|October 14, 2021
The Discovery of a Low-energy Excess in Cosmic-Ray Iron: Evidence of the Past Supernova Activity in the Local BubbleM J Boschini, S Della Torre, M Gervasi, et al.The Astrophysical Journal. Supplement Series|October 29, 2021
Inference of the Local Interstellar Spectra of Cosmic-Ray Nuclei Z ⩽ 28 with the GalProp-HelMod FrameworkM J Boschini, S Della Torre, M Gervasi, et al.The Astrophysical Journal. Supplement Series|November 15, 2021
Erratum: "Inference of the Local Interstellar Spectra of Cosmic-Ray Nuclei Z ⩽ 28 with the GALPROP-HELMOD Framework" (2020, ApJS, 250, 27)M J Boschini, S Della Torre, M Gervasi, et al.The Astrophysical Journal|October 14, 2021
Deciphering the Local Interstellar Spectra of Primary Cosmic-Ray Species with helmodM J Boschini, S Della Torre, M Gervasi, et al.The Astrophysical Journal|October 14, 2021
HelMod in the Works: From Direct Observations to the Local Interstellar Spectrum of Cosmic-Ray ElectronsM J Boschini, S Della Torre, M Gervasi, et al.Breast Cancer Research and Treatment|November 3, 2016
Metronomic chemotherapy with oral vinorelbine (mVNR) and capecitabine (mCAPE) in advanced HER2-negative breast cancer patients: is it a way to optimize disease control? Final results of the VICTOR-2 studyM E Cazzaniga, L Cortesi, A Ferzi, et al.Pageof 5